Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) (1)
Country
  • Australia (1)
  • Belgium (1)
  • Canada (1)
  • Denmark (1)
  • Egypt (1)
  • France (1)
  • Hungary (1)
  • Italy (1)
  • Netherlands (1)
  • New Zealand (1)
  • Norway (1)
  • Poland (1)
  • Slovakia (1)
  • Slovenia (1)
  • South Africa (1)
  • Sweden (1)
  • Switzerland (1)
  • United Kingdom (1)
Source
  • isrctn (1)
Phase
  • ongoing (1)

Country: Netherlands,Slovakia,France,Canada,United Kingdom,South Africa,Belgium,Italy,Norway
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium) Update Il y a 5 ans

Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma (NHL): a phase III randomised clinical trial (Intergroup Collaborative Study) Not provided at time of registration

  • Country Australia, Belgium, Canada, Denmark, Egypt, France, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, South Africa, Sweden, Switzerland, United Kingdom,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.